Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
2001 4
2002 4
2003 2
2004 5
2005 5
2006 9
2007 10
2008 12
2009 12
2010 7
2011 6
2012 4
2013 5
2014 3
2015 2
2016 2
2017 1
2018 3
2019 6
2020 6
2021 8
2022 2
2023 10
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
ABCG2: a perspective.
Robey RW, To KK, Polgar O, Dohse M, Fetsch P, Dean M, Bates SE. Robey RW, et al. Adv Drug Deliv Rev. 2009 Jan 31;61(1):3-13. doi: 10.1016/j.addr.2008.11.003. Epub 2008 Dec 16. Adv Drug Deliv Rev. 2009. PMID: 19135109 Free PMC article. Review.
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib.
Pang Y, Li Q, Sergi Z, Yu G, Sang X, Kim O, Wang H, Ranjan A, Merchant M, Oudit B, Robey RW, Soheilian F, Tran B, Núñez FJ, Zhang M, Song H, Zhang W, Davis D, Gilbert MR, Gottesman MM, Liu Z, Khan J, Thomas CJ, Castro MG, Gujral TS, Wu J. Pang Y, et al. Among authors: robey rw. bioRxiv [Preprint]. 2024 Jan 2:2023.06.29.547143. doi: 10.1101/2023.06.29.547143. bioRxiv. 2024. PMID: 37786680 Free PMC article. Preprint.
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.
Hebron KE, Wan X, Roth JS, Liewehr DJ, Sealover NE, Frye WJE, Kim A, Stauffer S, Perkins OL, Sun W, Isanogle KA, Robinson CM, James A, Awasthi P, Shankarappa P, Luo X, Lei H, Butcher D, Smith R, Edmondson EF, Chen JQ, Kedei N, Peer CJ, Shern JF, Figg WD, Chen L, Hall MD, Difilippantonio S, Barr FG, Kortum RL, Robey RW, Vaseva AV, Khan J, Yohe ME. Hebron KE, et al. Among authors: robey rw. Clin Cancer Res. 2023 Jan 17;29(2):472-487. doi: 10.1158/1078-0432.CCR-22-1646. Clin Cancer Res. 2023. PMID: 36322002 Free PMC article.
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance.
Alyateem G, Wade HM, Bickert AA, Lipsey CC, Mondal P, Smith MD, Labib RM, Mock BA, Robey RW, Gottesman MM. Alyateem G, et al. Among authors: robey rw. Cancer Gene Ther. 2023 Aug;30(8):1043-1050. doi: 10.1038/s41417-023-00608-z. Epub 2023 Apr 7. Cancer Gene Ther. 2023. PMID: 37029320 Free PMC article. Review.
Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery.
Quinlan JA, Inglut CT, Srivastava P, Rahman I, Stabile J, Gaitan B, Arnau Del Valle C, Baumiller K, Gaur A, Chiou WA, Karim B, Connolly N, Robey RW, Woodworth GF, Gottesman MM, Huang HC. Quinlan JA, et al. Among authors: robey rw. Adv Sci (Weinh). 2024 May;11(17):e2302872. doi: 10.1002/advs.202302872. Epub 2024 Mar 6. Adv Sci (Weinh). 2024. PMID: 38445882 Free PMC article.
The challenge of exploiting ABCG2 in the clinic.
Robey RW, Ierano C, Zhan Z, Bates SE. Robey RW, et al. Curr Pharm Biotechnol. 2011 Apr;12(4):595-608. doi: 10.2174/138920111795163913. Curr Pharm Biotechnol. 2011. PMID: 21118093 Free PMC article. Review.
122 results